We are live on ! Find out more
TM

Tikvah Management Portfolio holdings

AUM $323M
1-Year Est. Return 69.61%
This Fund
S&P 500
This Quarter Est. Return
-16.19%
1 Year Est. Return
+69.61%
3 Year Est. Return
+173.03%
5 Year Est. Return
+103.33%
10 Year Est. Return
+586.01%
AUM
$313M
AUM Growth
-$45.8M
Cap. Flow
+$9.46M
Cap. Flow %
3.02%
Top 10 Hldgs %
84.14%
Holding
25
New
4
Increased
5
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$58.5M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$8.68M
3
AVDX
AvidXchange
AVDX
+$5.66M
4
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
+$5.46M
5
GPGI
GPGI Inc
GPGI
+$3.73M

Top Sells

Rank Stock Value
1
BIO.B icon
Bio-Rad Laboratories Class B
BIO.B
+$73.3M
2
LAB icon
Standard BioTools
LAB
+$4.9M

Sector Composition

Rank Sector Weight
1 Healthcare 33.9%
2 Consumer Discretionary 19.57%
3 Communication Services 16.43%
4 Technology 13.3%
5 Consumer Staples 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMZN icon
1
Amazon
AMZN
$2.92T
$61.2M 19.57%
375,480
– –
BIO icon
2
Bio-Rad Laboratories Class A
BIO
$8.71B
$54.6M 17.47%
+97,027
New +$58.5M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.36T
$35M 11.19%
251,700
– –
AVDX
4
DELISTED
AvidXchange
AVDX
$22.7M 7.25%
2,817,798
+561,280
+25% +$5.66M
SLGC
5
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$20.5M 6.55%
2,554,240
+984,200
+63% +$8.68M
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$17.6M 5.63%
38,994
– –
GOOG icon
7
Alphabet (Google) Class C
GOOG
$4.36T
$16.4M 5.24%
117,380
– –
QTRX icon
8
Quanterix
QTRX
$164M
$12.7M 4.07%
436,119
+90,600
+26% +$2.77M
BNFT
9
DELISTED
Benefitfocus, Inc.
BNFT
$12.3M 3.93%
975,118
– –
WEJO
10
DELISTED
Wejo Group Limited Common Shares
WEJO
$10.1M 3.23%
2,500,000
– –
SMRT icon
11
SmartRent
SMRT
$195M
$8.82M 2.82%
1,743,222
– –
ATYR
12
aTyr Pharma
ATYR
$47.6M
$7.23M 2.31%
1,350,833
+125,000
+10% +$708K
NAUT icon
13
Nautilus Biotechnolgy
NAUT
$124M
$6.46M 2.07%
1,488,895
+257,060
+21% +$1.06M
VWO icon
14
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$4.69M 1.5%
101,580
– –
STRA icon
15
Strategic Education
STRA
$1.85B
$4.48M 1.43%
67,489
– –
OMIC
16
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$4.46M 1.43%
+23,587
New +$5.46M
GPGI
17
GPGI Inc
GPGI
$3.83B
$3.78M 1.21%
+600,036
New +$3.73M
CMPOW
18
DELISTED
CompoSecure Inc Warrant
CMPOW
$3.17M 1.01%
2,045,637
– –
INDA icon
19
iShares MSCI India ETF
INDA
$6.89B
$2.1M 0.67%
47,200
– –
IAU icon
20
iShares Gold Trust
IAU
$62.9B
$1.85M 0.59%
50,250
– –
WEJOW
21
DELISTED
Wejo Group Limited Warrant
WEJOW
$1.01M 0.32%
1,748,737
– –
ALLG.WS
22
DELISTED
Allego N.V. Warrants
ALLG.WS
$998K 0.32%
+950,000
New +$1.12M
LGV.WS
23
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$529K 0.17%
1,259,790
– –
BIO.B icon
24
Bio-Rad Laboratories Class B
BIO.B
– –
-97,027
Closed -$73.3M
LAB icon
25
Standard BioTools
LAB
$340M
– –
-1,250,000
Closed -$4.9M

Similar funds

GIM
Gold Investment Management Edmonton, Alberta, Canada $323M AUM 38.72% 1-Year Est. Return
CRI
Commonwealth Retirement Investments Richmond, Virginia $323M AUM 24.17% 1-Year Est. Return
BCP
Bayberry Capital Partners New York $323M AUM 27.31% 1-Year Est. Return
UOC
University of Chicago Chicago, Illinois $323M AUM 14.1% 1-Year Est. Return
BEP
Bluescape Energy Partners Dallas, Texas $322M AUM 18.33% 1-Year Est. Return
AIA
AIMZ Investment Advisors Los Altos, California $324M AUM 18.77% 1-Year Est. Return
FAL
Focused Alpha LLC Denver, Colorado $324M AUM
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return

Tikvah Management's Q1 2022 Portfolio in Review

As of Q1 2022, Tikvah Management held 25 positions worth $313M, down 13% from $359M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Tikvah Management deployed $9.46M of net new capital in Q1 2022, opening 4 new positions and adding to 5 existing holdings. Its largest new stake was Bio-Rad Laboratories Class A: 97,027 shares worth $54.6M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the most notable exit was Bio-Rad Laboratories Class B, an estimated $73.3M sold.

  • Tikvah Management's largest Q1 2022 buy was Bio-Rad Laboratories Class A: 97,027 shares worth $54.6M.
  • Tikvah Management added most to SomaLogic, Inc. Class A Common Stock in Q1 2022, an estimated $8.68M increase.
  • Tikvah Management fully exited Bio-Rad Laboratories Class B in Q1 2022, selling an estimated $73.3M.
  • Tikvah Management's ten largest holdings make up 84% of its $313M portfolio in Q1 2022.
  • Tikvah Management opened 4 new positions and closed 2 in Q1 2022.
  • Tikvah Management's portfolio value fell 13% quarter-over-quarter to $313M.

Based on Tikvah Management's 13F filing for Q1 2022, filed 16 May 2022.